Loading company…
Cambridge-based Rheos Medicines develops drug delivery systems aimed at improving treatment effectiveness and patient outcomes.
Founded in 2017 in Cambridge, US, Rheos Medicines, Inc. develops a proprietary drug delivery system intended to improve the bioavailability and targeted delivery of active ingredients, sold mainly to hospitals, clinics and patients in North America and Europe. Revenue comes from direct sales and tiered pricing to healthcare institutions under B2B contracts. In October 2018 it raised USD 21.00 mn, and it plans to use the funds for new products and expansion into Europe and Asia by 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in